journal article Dec 08, 2025

NPY Y 1 and Y 2 receptors in the regulation of mouse recognition and procedural memory: Interplay with cellular signalling, noradrenergic transmission and monoamine concentrations

British Journal of Pharmacology Vol. 183 No. 9 pp. 1958-1974 · Wiley
View at Publisher Save 10.1111/bph.70287
Abstract
Abstract

Background and Purpose

Recognition and procedural memory are modulated by the noradrenergic system, whose terminals release noradrenaline along with neuropeptide Y, acting via Y1 and Y2 receptors. This study aims to investigate the role of Y1 and Y2 receptor antagonists (BMS‐193885 and SF‐11) on recognition and procedural memory, including their co‐administration with clenbuterol, a β
2
‐adrenoceptor agonist, with additional focus on the molecular mechanisms underlying memory‐related behavioural changes.



Experimental Approach
Recognition memory was assessed in mice using the novel object recognition task. Motor learning and procedural memory were evaluated in the accelerating rotarod test. Memory‐related behavioural outcomes were complemented by analyses of NPY levels, the phosphorylation status of CaMKII and ERK1/2, along with the concentrations of 5‐HT, dopamine, noradrenaline and its metabolite in selected brain regions, including the prefrontal cortex, hippocampus and cerebellum.


Key Results

SF‐11 at 5 mg·kg
−1
impaired recognition memory, prolonged procedural memory retention and inhibited CaMKII, but at 20 mg·kg
−1
, SF‐11 disrupted both recognition and procedural memory increasing NPY. BMS‐193885, at 5 mg·kg
−1
, prolonged procedural memory retention, but at 20 mg·kg
−1
, it impaired long‐term recognition memory, prolonged procedural memory retention, increased NPY and decreased phospho‐CaMKII. Clenbuterol enhanced procedural memory retention, but this pro‐cognitive effect was diminished by co‐administration with either Y receptor antagonist, which correlated with decreased noradrenaline levels.



Conclusions and Implications
NPY receptor antagonists modulate memory processes in a dose‐ and memory‐type‐dependent manner, and these effects appear to be linked to hippocampal function. NPY receptors may serve as therapeutic targets to treat cognitive impairments.
Topics

No keywords indexed for this article. Browse by subject →

References
51
[3]
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

Stephen P. H. Alexander, Doriano Fabbro, Eamonn Kelly et al.

British Journal of Pharmacology 10.1111/bph.16181
[30]
Novel Object Recognition Test for the Investigation of Learning and Memory in Mice

Lindsay M. Lueptow

Journal of Visualized Experiments 10.3791/55718
[36]
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia et al.

PLOS Biology 10.1371/journal.pbio.3000410
[39]
Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus

Janine I. Rossato, Andressa Radiske, Cristiano A. Köhler et al.

Neurobiology of Learning and Memory 10.1016/j.nlm.2013.07.012
[42]
Fiji: an open-source platform for biological-image analysis

Johannes Schindelin, Ignacio Arganda-Carreras, Erwin Frise et al.

Nature Methods 10.1038/nmeth.2019

Showing 50 of 51 references

Related

You May Also Like